Research Leaders

  • Portrait of Dr. Robert A. Winn
    Cancer Center Director

    Robert A. Winn, MD

    Senior Associate Dean for Cancer Research Innovation and Professor, Department of Cancer and Cellular Biology, Lewis Katz School of Medicine at Temple University
    Professor, Cancer Prevention and Control Program, Fox Chase Cancer Center
     
  • David Weist
    Chief Science Officer

    David Wiest, PhD

    Scientific Director of the Research Institute of Fox Chase Cancer Center
    Professor, Nuclear Dynamics and Cancer Program
     

Associate Directors

  • Population Science

    Carolyn Y. Fang, PhD

    Professor, Cancer Prevention and Control

    Carolyn Y. Fang studies how psychosocial and behavioral factors influence cancer risk and outcomes, particularly in underserved populations. Her work has made significant contributions to informing evidence-based approaches for addressing cancer health disparities.

  • System Integration

    Erica Golemis, PhD, Professor

    Deputy Chief Science Officer
    Professor, Cancer Signaling and Microenvironment
    William Wikoff Smith Chair in Cancer Research

    As Associate Director for System Integration, Erica Golemis works with Fox Chase and Temple scientists to develop relationships that will lead Fox Chase into the future. As Senior Associate Dean of Research, she directs the overall research enterprise at the Lewis Katz School of Medicine, she focuses on identifying and supporting research synergies that advance cancer research and cancer care.

  • Administration & Planning

    John Gricoski

    Vice President, Research Administration

    John Gricoski is responsible for administration of the center, including oversight of research operating and capital budgets, and laboratory space planning. He also manages the NCI Cancer Center Support Grant. Gricoski has an MBA in finance and is a licensed Pennsylvania CPA.

  • Associate Director for Diversity, Equity, Inclusion and Accessibility

    Camille Ragin, PhD, MPH

    Associate Director for Cancer Disparities Research and Research Integration

    Camille Ragin’s research focuses on gene-environment interactions and cancer health disparities. Her work applies molecular biomarkers, genomics, and public health tools to cancer research in African American communities and African-descended populations worldwide.

  • Glenn F. Rall, PhD
    Cancer Research Training and Education

    Glenn F. Rall, PhD

    Chief Academic Officer
    Professor, Cancer Signaling and Microenvironment

    Rall focuses on the intersection of virology, immunology, and neurobiology. As associate director of education and training, Rall oversees all faculty affairs, as well as mentoring and education programs.

  • Charnita Zeigler-Johnson
    Community Outreach and Engagement (COE)

    Charnita Zeigler-Johnson, PhD, MPH

    Charnita Zeigler-Johnson, PhD, MPH, is Associate Director of Community Outreach and Engagement at Fox Chase Cancer Center, where she works with community partners, cancer center leadership, and researchers to address cancer disparities and integrate community-engaged research across Fox Chase and Temple Health. A well-funded investigator with more than 75 peer-reviewed publications, her research focuses on prostate cancer disparities and expanding lung cancer screening access and adherence among vulnerable populations. Zeigler-Johnson earned her PhD and MPH in epidemiology from the University of Pittsburgh and is a leader in several national and international cancer organizations, including the African Caribbean Cancer Consortium, American Association for Cancer Research, and Pennsylvania Cancer Coalition.

  • Namrata Vijayvergia, MD
    Namrata Vijayvergia, MD

    Namrata Vijayvergia, MD

    Chief of the Division of Gastrointestinal Medical OncologyAssociate Professor
    Department of Hematology/Oncology
    Associate Director for Clinical Research

    Namrata “Neena” Vijayvergia, MD, is a nationally recognized medical oncologist specializing in gastrointestinal cancers and rare neuroendocrine tumors. Her clinical and translational research focuses on developing novel therapeutic strategies and expanding clinical trial opportunities to improve outcomes for patients with gastrointestinal malignancies. She also provides leadership in medical oncology and serves as Section Chief of Gastrointestinal Medical Oncology at Fox Chase.

  • David S. Weinberg, MD, MSC Headshot
    Prevention and Screening

    David S. Weinberg, MD, MSC

    Associate Director of Cancer Screening and Prevention for the Institute for Cancer Research
    Vice President/Physician Lead of the Cancer Screening and Prevention Service Line 

    David Weinberg, MD, MSc, joined Fox Chase Cancer Center in 2001 as Director of Gastroenterology and served as Chair of the Department of Medicine from 2008 to 2026. A distinguished cancer researcher with more than 250 publications and continuous NIH/NCI funding since 1995, his work focuses on gastrointestinal cancers, cancer screening and prevention, including strategies to increase screening utilization and advance the use of novel biomarkers. Weinberg is Co-Editor-in-Chief of Gastroenterology and has held leadership roles with organizations including the American Board of Internal Medicine, American College of Physicians, and American Gastroenterological Association.

  • Matthew R. Zibelman headshot
    Clinical Research Education

    Matthew R. Zibelman, MD

    Associate Professor, Department of Hematology/Oncology
    Director of Clinical Research Education

    Matthew Zibelman, MD, is a nationally recognized genitourinary medical oncologist and clinical investigator specializing in kidney, bladder, and prostate cancers. His research focuses on developing innovative therapies and advancing clinical trials to improve outcomes for patients with genitourinary malignancies. He also plays a significant role in clinical and translational research at Fox Chase, including leadership of genitourinary clinical research.
     

Research Program Leaders

  • Cancer Prevention and Control Program

    Margie L. Clapper, PhD

    Co-Leader, Cancer Prevention and Control
    Professor
    Samuel M.V. Hamilton Chair in Cancer Prevention

     

  • Cancer Prevention and Control Program

    Michael J. Hall, MD, MS

    Chair and Professor, Department of Clinical Genetics
    Director, Gastrointestinal Risk Assessment
    Co-Leader, Cancer Prevention and Control Program

     

  • Edna Cukierman
    Cancer Signaling and Microenvironment Program

    Edna (Eti) Cukierman, PhD

    Marvin & Concetta Greenberg Chair in Pancreatic Cancer Research
    ACS Wilmott Family Professor of Pancreatic Cancer
    Co-Leader, Cancer Signaling and Microenvironment
    Founding Director, Marvin & Concetta Greenberg Pancreatic Cancer Institute
    Co-Director, Histopathology Facility – Spatial Immunoproteomics
     
  • Roland L. Dunbrack, Jr, PhD
    Cancer Signaling and Microenvironment Program

    Roland L. Dunbrack, Jr, PhD 

    Co-Leader and Professor, Cancer Signaling and Microenvironment Program
    Director, Molecular Modeling and Screening Facility
    Director, Organic Synthesis Facility
     

     

  • Tomasz Skorski
    Nuclear Dynamics and Cancer Program

    Tomasz Skorski, MD, PhD, DSc

    Co-Leader and Professor, Nuclear Dynamics and Cancer
    Director, Fels Cancer Institute for Personalized Medicine
    Professor, Department of Cancer and Cellular Biology
  • John Whetstine
    Nuclear Dynamics and Cancer Program

    Johnathan R. Whetstine, PhD

    Co-Leader and Professor, Nuclear Dynamics and Cancer Program
    Director, Cancer Epigenetics Institute
    Jack Schultz Chair in Basic Science